A novel vs reference DAPT regimen after staged PCI was found to reduce the risk for bleeding in patients with acute coronary syndrome.
Second study shows reduction in cardiovascular diagnostic testing across the world during pandemic
Peripheral lymphatic vessels may not compensate for interstitial accumulation and fluid extravasation in HFpEF.
Among treated individuals, blood pressure control at baseline inversely linked to global cognitive, memory test scores.
All-cause mortality risk increased with interarm systolic blood pressure difference magnitude from ≥5 mm Hg threshold
However, the new study finds a higher risk of kidney replacement therapy with continuation of angiotensin converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) therapy.
Researchers’ goal was to determine empagliflozin’s impact on the central hemodynamic parameters of patients with heart failure with reduced ejection fraction.
Greater eGFR variability may identify individuals at higher mortality risk whether or not they have chronic kidney disease, according to investigators.
Testing correlated with increased likelihood of initiation of MRA therapy and with better BP control over time
Any increase in blood pressure was associated with increased WMH, even below 140, 90 mmHg for SBP, DBP